SS/Jr |
heart right ventricle deoxyribonucleic acid level to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
heart right ventricle DNA amount |
male |
98 days
| 11 |
|
1.1 |
ug/g |
0.1 |
0.33 |
spectrophotometry |
0.0 |
0 |
|
|
69044 |
1096 |
COP.DA-(D16Rat12-D16Rat90)/Mco |
plasma triglyceride level |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood triglyceride amount |
not specified |
105 days
| 8 |
|
0.45 |
mmol/l |
0.06 |
0.16 |
spectrophotometry |
0.0 |
0 |
|
|
68558 |
933 |
COP.DA-(D16Rat12-D16Rat90)/Mco |
plasma triglyceride level |
fasting (for 16 hours) |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood triglyceride amount |
not specified |
105 days
| 15 |
|
0.23 |
mmol/l |
0.03 |
0.12 |
spectrophotometry |
0.0 |
0 |
|
|
68561 |
933 |
Hsd:WI |
liver malondialdehyde level to liver weight ratio |
fasting (for 16 hours) |
Aycan IO, et al., Int J Surg. 2014;12(3):213-8. doi: 10.1016/j.ijsu.2013.12.013. Epub 2014 Jan 2. |
liver malondialdehyde amount |
not specified |
0 days
| 10 |
|
0.37 |
nmol/g |
0.03 |
0.08 |
spectrophotometry |
0.0 |
0 |
|
|
85614 |
1618 |
Hsd:WI |
liver malondialdehyde level to liver weight ratio |
acetaminophen (500 mg/kg) (for 1 days) then fasting (for 16 hours) |
Aycan IO, et al., Int J Surg. 2014;12(3):213-8. doi: 10.1016/j.ijsu.2013.12.013. Epub 2014 Jan 2. |
liver malondialdehyde amount |
not specified |
0 days
| 10 |
|
0.71 |
nmol/g |
0.05 |
0.15 |
spectrophotometry |
0.0 |
0 |
|
|
85616 |
1618 |
Hsd:WI |
serum malondialdehyde level |
acetaminophen (500 mg/kg) (for 1 days) then thymoquinone (15 mg/kg) (for 1 days) then fasting (for 16 hours) |
Aycan IO, et al., Int J Surg. 2014;12(3):213-8. doi: 10.1016/j.ijsu.2013.12.013. Epub 2014 Jan 2. |
blood malondialdehyde amount |
not specified |
0 days
| 10 |
|
162.5 |
nmol/l |
12.43 |
39.3 |
spectrophotometry |
0.0 |
0 |
|
|
85613 |
1618 |
F344/NHsd |
serum alanine aminotransferase activity level |
fasting (between 12 and 15 hours) then acetaminophen (1.5 g/kg) (for 1 days) |
McGill MR, et al., Toxicol Appl Pharmacol. 2012 Nov 1;264(3):387-94. doi: 10.1016/j.taap.2012.08.015. Epub 2012 Aug 23. |
blood alanine transaminase amount |
not specified |
56 days-84 days |
4 |
|
101.0 |
U/l |
7.0 |
14.0 |
spectrophotometry |
0.0 |
0 |
|
|
84756 |
1601 |
Y59/Zgd |
bone phosphorus content |
naringenin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
bone mineral mass |
female |
105 days
| 10 |
mg/g bone tissue |
77.87 |
mg/g |
0.78 |
2.47 |
spectrophotometry |
0.0 |
0 |
660nm; Varian Cary 50 |
right |
97435 |
1758 |
Y59/Zgd |
kidney malondialdehyde level |
alendronate (40 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
kidney malondialdehyde amount |
female |
105 days
| 5 |
|
10.66 |
nmol/mg |
0.48 |
1.08 |
spectrophotometry |
0.0 |
0 |
|
|
97495 |
1758 |
Y59/Zgd |
kidney malondialdehyde level |
chrysin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
kidney malondialdehyde amount |
female |
105 days
| 5 |
|
7.28 |
nmol/mg |
0.59 |
1.31 |
spectrophotometry |
0.0 |
0 |
|
|
97497 |
1758 |
Y59/Zgd |
liver malondialdehyde level |
vitamin A (80 mg/kg/d) (for 14 days) and naringenin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
liver malondialdehyde amount |
female |
105 days
| 5 |
|
8.78 |
nmol/mg |
0.71 |
1.59 |
spectrophotometry |
0.0 |
0 |
|
|
97484 |
1758 |
Y59/Zgd |
liver malondialdehyde level |
quercetin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
liver malondialdehyde amount |
female |
105 days
| 5 |
|
6.29 |
nmol/mg |
0.08 |
0.19 |
spectrophotometry |
0.0 |
0 |
|
|
97486 |
1758 |
Y59/Zgd |
liver malondialdehyde level |
naringenin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
liver malondialdehyde amount |
female |
105 days
| 5 |
|
8.94 |
nmol/mg |
1.28 |
2.86 |
spectrophotometry |
0.0 |
0 |
|
|
97488 |
1758 |
Y59/Zgd |
kidney malondialdehyde level |
naringenin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
kidney malondialdehyde amount |
female |
105 days
| 5 |
|
8.41 |
nmol/mg |
0.5 |
1.11 |
spectrophotometry |
0.0 |
0 |
|
|
97498 |
1758 |
Y59/Zgd |
bone phosphorus content |
vitamin A (80 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
bone mineral mass |
female |
105 days
| 10 |
mg/g bone tissue |
69.4 |
mg/g |
0.28 |
0.9 |
spectrophotometry |
0.0 |
0 |
660nm; Varian Cary 50 |
right |
97427 |
1758 |
Y59/Zgd |
bone phosphorus content |
ethanol (0.5 %) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
bone mineral mass |
female |
105 days
| 10 |
mg/g bone tissue |
75.5 |
mg/g |
0.78 |
2.47 |
spectrophotometry |
0.0 |
0 |
660nm; Varian Cary 50 |
right |
97432 |
1758 |
Y59/Zgd |
kidney malondialdehyde level |
vitamin A (80 mg/kg/d) (for 14 days) and quercetin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
kidney malondialdehyde amount |
female |
105 days
| 5 |
|
8.48 |
nmol/mg |
0.37 |
0.82 |
spectrophotometry |
0.0 |
0 |
|
|
97492 |
1758 |
WKY.GHS-(D1Rat32-D1Mit32) |
urine calcium excretion rate |
controlled calcium content diet (1.2 %) (between 5 and 9 days) |
Hoopes RR Jr, et al., J Am Soc Nephrol. 2006 May;17(5):1292-304. Epub 2006 Apr 12. |
urine calcium amount |
male |
61 days
| 8 |
|
1.67 |
mg/d |
0.25 |
0.71 |
spectrophotometry |
0.0 |
0 |
|
|
67889 |
831 |
WKY |
urine calcium excretion rate |
controlled calcium content diet (1.2 %) (between 5 and 9 days) |
Hoopes RR Jr, et al., J Am Soc Nephrol. 2006 May;17(5):1292-304. Epub 2006 Apr 12. |
urine calcium amount |
female |
61 days
| 8 |
|
2.11 |
mg/d |
0.18 |
0.5 |
spectrophotometry |
0.0 |
0 |
|
|
67892 |
831 |
SS.MNS-(D2Mit6-Adh1)/Ayd |
heart right ventricle deoxyribonucleic acid level to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
heart right ventricle DNA amount |
male |
98 days
| 5 |
|
1.13 |
ug/g |
0.05 |
0.11 |
spectrophotometry |
0.0 |
0 |
|
|
69040 |
1096 |
COP/OlaHsd |
plasma free fatty acids level |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood free fatty acid amount |
not specified |
105 days
| 14 |
|
0.12 |
mmol/l |
0.01 |
0.04 |
spectrophotometry |
0.0 |
0 |
|
|
68563 |
933 |
COP.DA-(D3Rat233-D3Mgh14)/Mco |
plasma free fatty acids level |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood free fatty acid amount |
not specified |
105 days
| 16 |
|
0.1 |
mmol/l |
0.01 |
0.04 |
spectrophotometry |
0.0 |
0 |
|
|
68565 |
933 |
COP.DA-(D16Rat12-D16Rat90)/Mco |
plasma free fatty acids level |
fasting (for 16 hours) |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood free fatty acid amount |
not specified |
105 days
| 15 |
|
0.29 |
mmol/l |
0.03 |
0.12 |
spectrophotometry |
0.0 |
0 |
|
|
68567 |
933 |
SS.MNS-(D2Mit6-Adh1)/Ayd |
heart left ventricle deoxyribonucleic acid level to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
heart left ventricle DNA amount |
male |
98 days
| 5 |
|
3.0 |
ug/g |
0.2 |
0.45 |
spectrophotometry |
0.0 |
0 |
DNA extraction method |
|
69035 |
1096 |
Hsd:SD |
serum alanine aminotransferase activity level |
fasting (between 12 and 15 hours) then acetaminophen (2 g/kg) (for 1 days) |
McGill MR, et al., Toxicol Appl Pharmacol. 2012 Nov 1;264(3):387-94. doi: 10.1016/j.taap.2012.08.015. Epub 2012 Aug 23. |
blood alanine transaminase amount |
not specified |
56 days-84 days |
4 |
|
31.0 |
U/l |
4.0 |
8.0 |
spectrophotometry |
0.0 |
0 |
|
|
84759 |
1601 |
Y59/Zgd |
bone phosphorus content |
vitamin A (80 mg/kg/d) (for 14 days) and chrysin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
bone mineral mass |
female |
105 days
| 10 |
mg/g bone tissue |
76.25 |
mg/g |
0.88 |
2.78 |
spectrophotometry |
0.0 |
0 |
660nm; Varian Cary 50 |
right |
97430 |
1758 |
Y59/Zgd |
liver malondialdehyde level |
ethanol (0.5 %) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
liver malondialdehyde amount |
female |
105 days
| 5 |
|
8.39 |
nmol/mg |
0.63 |
1.4 |
spectrophotometry |
0.0 |
0 |
|
|
97479 |
1758 |
Y59/Zgd |
kidney malondialdehyde level |
quercetin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
kidney malondialdehyde amount |
female |
105 days
| 5 |
|
5.83 |
nmol/mg |
0.36 |
0.8 |
spectrophotometry |
0.0 |
0 |
|
|
97496 |
1758 |
Y59/Zgd |
liver malondialdehyde level |
vitamin A (80 mg/kg/d) (for 14 days) and quercetin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
liver malondialdehyde amount |
female |
105 days
| 5 |
|
8.33 |
nmol/mg |
0.54 |
1.21 |
spectrophotometry |
0.0 |
0 |
|
|
97482 |
1758 |
Y59/Zgd |
liver malondialdehyde level |
chrysin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
liver malondialdehyde amount |
female |
105 days
| 5 |
|
6.58 |
nmol/mg |
0.25 |
0.55 |
spectrophotometry |
0.0 |
0 |
|
|
97487 |
1758 |
Y59/Zgd |
bone phosphorus content |
chrysin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
bone mineral mass |
female |
105 days
| 10 |
mg/g bone tissue |
76.67 |
mg/g |
0.64 |
2.03 |
spectrophotometry |
0.0 |
0 |
660nm; Varian Cary 50 |
right |
97434 |
1758 |
Y59/Zgd |
kidney malondialdehyde level |
vitamin A (80 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
kidney malondialdehyde amount |
female |
105 days
| 5 |
|
11.75 |
nmol/mg |
0.66 |
1.48 |
spectrophotometry |
0.0 |
0 |
|
|
97490 |
1758 |
SS.MNS-(D2Mit6-D2Rat166)/Ayd |
heart right ventricle deoxyribonucleic acid level to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
heart right ventricle DNA amount |
male |
98 days
| 4 |
|
0.5 |
ug/g |
0.09 |
0.18 |
spectrophotometry |
0.0 |
0 |
|
|
69041 |
1096 |
SS.MNS-(D2Mit6-D2Rat303)/Ayd |
heart left ventricle deoxyribonucleic acid level to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
heart left ventricle DNA amount |
male |
98 days
| 5 |
|
5.0 |
ug/g |
0.5 |
1.12 |
spectrophotometry |
0.0 |
0 |
|
|
69037 |
1096 |
Hsd:WI |
liver malondialdehyde level to liver weight ratio |
thymoquinone (15 mg/kg) (for 1 days) then fasting (for 16 hours) |
Aycan IO, et al., Int J Surg. 2014;12(3):213-8. doi: 10.1016/j.ijsu.2013.12.013. Epub 2014 Jan 2. |
liver malondialdehyde amount |
not specified |
0 days
| 10 |
|
0.33 |
nmol/g |
0.02 |
0.07 |
spectrophotometry |
0.0 |
0 |
|
|
85615 |
1618 |
F344/NHsd |
serum alanine aminotransferase activity level |
fasting (between 12 and 15 hours) then vehicle control condition (for 1 days) |
McGill MR, et al., Toxicol Appl Pharmacol. 2012 Nov 1;264(3):387-94. doi: 10.1016/j.taap.2012.08.015. Epub 2012 Aug 23. |
blood alanine transaminase amount |
not specified |
56 days-84 days |
4 |
|
35.0 |
U/l |
11.0 |
22.0 |
spectrophotometry |
0.0 |
0 |
|
|
84754 |
1601 |
Hsd:WI |
serum malondialdehyde level |
fasting (for 16 hours) |
Aycan IO, et al., Int J Surg. 2014;12(3):213-8. doi: 10.1016/j.ijsu.2013.12.013. Epub 2014 Jan 2. |
blood malondialdehyde amount |
not specified |
0 days
| 10 |
|
133.1 |
nmol/l |
9.42 |
29.8 |
spectrophotometry |
0.0 |
0 |
|
|
85610 |
1618 |
Hsd:WI |
serum malondialdehyde level |
thymoquinone (15 mg/kg) (for 1 days) then fasting (for 16 hours) |
Aycan IO, et al., Int J Surg. 2014;12(3):213-8. doi: 10.1016/j.ijsu.2013.12.013. Epub 2014 Jan 2. |
blood malondialdehyde amount |
not specified |
0 days
| 10 |
|
119.7 |
nmol/l |
8.41 |
26.6 |
spectrophotometry |
0.0 |
0 |
|
|
85611 |
1618 |
SS/Jr |
heart left ventricle deoxyribonucleic acid level to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
heart left ventricle DNA amount |
male |
98 days
| 11 |
|
5.8 |
ug/g |
0.6 |
1.99 |
spectrophotometry |
0.0 |
0 |
|
|
69039 |
1096 |
COP.DA-(D3Rat233-D3Mgh14)/Mco |
plasma triglyceride level |
fasting (for 16 hours) |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood triglyceride amount |
not specified |
105 days
| 20 |
|
0.34 |
mmol/l |
0.03 |
0.13 |
spectrophotometry |
0.0 |
0 |
|
|
68562 |
933 |
Y59/Zgd |
liver malondialdehyde level |
vitamin A (80 mg/kg/d) (for 14 days) and alendronate (40 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
liver malondialdehyde amount |
female |
105 days
| 5 |
|
8.26 |
nmol/mg |
0.44 |
0.98 |
spectrophotometry |
0.0 |
0 |
|
|
97481 |
1758 |
Hsd:WI |
serum malondialdehyde level |
acetaminophen (500 mg/kg) (for 1 days) then fasting (for 16 hours) |
Aycan IO, et al., Int J Surg. 2014;12(3):213-8. doi: 10.1016/j.ijsu.2013.12.013. Epub 2014 Jan 2. |
blood malondialdehyde amount |
not specified |
0 days
| 10 |
|
253.4 |
nmol/l |
17.9 |
56.6 |
spectrophotometry |
0.0 |
0 |
|
|
85612 |
1618 |
Hsd:SD |
serum alanine aminotransferase activity level |
fasting (between 12 and 15 hours) then acetaminophen (1 g/kg) (for 1 days) |
McGill MR, et al., Toxicol Appl Pharmacol. 2012 Nov 1;264(3):387-94. doi: 10.1016/j.taap.2012.08.015. Epub 2012 Aug 23. |
blood alanine transaminase amount |
not specified |
56 days-84 days |
4 |
|
41.0 |
U/l |
11.0 |
22.0 |
spectrophotometry |
0.0 |
0 |
|
|
84758 |
1601 |
Y59/Zgd |
liver malondialdehyde level |
vitamin A (80 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
liver malondialdehyde amount |
female |
105 days
| 5 |
|
11.41 |
nmol/mg |
0.68 |
1.51 |
spectrophotometry |
0.0 |
0 |
|
|
97480 |
1758 |
Y59/Zgd |
kidney malondialdehyde level |
vitamin A (80 mg/kg/d) (for 14 days) and chrysin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
kidney malondialdehyde amount |
female |
105 days
| 5 |
|
8.02 |
nmol/mg |
0.72 |
1.6 |
spectrophotometry |
0.0 |
0 |
|
|
97493 |
1758 |
Y59/Zgd |
kidney malondialdehyde level |
vitamin A (80 mg/kg/d) (for 14 days) and naringenin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
kidney malondialdehyde amount |
female |
105 days
| 5 |
|
7.99 |
nmol/mg |
0.6 |
1.34 |
spectrophotometry |
0.0 |
0 |
|
|
97494 |
1758 |
SS.MNS-(Mme-D2Rat131)/Ayd |
heart right ventricle deoxyribonucleic acid level to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
heart right ventricle DNA amount |
male |
98 days
| 5 |
|
1.1 |
ug/g |
0.2 |
0.45 |
spectrophotometry |
0.0 |
0 |
|
|
69043 |
1096 |
COP.DA-(D3Rat233-D3Mgh14)/Mco |
plasma triglyceride level |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood triglyceride amount |
not specified |
105 days
| 16 |
|
0.54 |
mmol/l |
0.07 |
0.28 |
spectrophotometry |
0.0 |
0 |
|
|
68559 |
933 |
COP/OlaHsd |
plasma free fatty acids level |
fasting (for 16 hours) |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood free fatty acid amount |
not specified |
105 days
| 20 |
|
0.23 |
mmol/l |
0.02 |
0.09 |
spectrophotometry |
0.0 |
0 |
|
|
68566 |
933 |
Y59/Zgd |
bone phosphorus content |
quercetin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
bone mineral mass |
female |
105 days
| 10 |
mg/g bone tissue |
76.25 |
mg/g |
0.54 |
1.7 |
spectrophotometry |
0.0 |
0 |
660nm; Varian Cary 50 |
right |
97433 |
1758 |
WKY |
urine calcium excretion rate |
controlled calcium content diet (1.2 %) (between 5 and 9 days) |
Hoopes RR Jr, et al., J Am Soc Nephrol. 2006 May;17(5):1292-304. Epub 2006 Apr 12. |
urine calcium amount |
male |
61 days
| 8 |
|
0.78 |
mg/d |
0.07 |
0.19 |
spectrophotometry |
0.0 |
0 |
|
|
67890 |
831 |
SS.MNS-(D2Mit6-D2Rat303)/Ayd |
heart right ventricle deoxyribonucleic acid level to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
heart right ventricle DNA amount |
male |
98 days
| 5 |
|
1.2 |
ug/g |
0.09 |
0.2 |
spectrophotometry |
0.0 |
0 |
|
|
69042 |
1096 |
COP/OlaHsd |
plasma triglyceride level |
fasting (for 16 hours) |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood triglyceride amount |
not specified |
105 days
| 20 |
|
0.29 |
mmol/l |
0.02 |
0.1 |
spectrophotometry |
0.0 |
0 |
|
|
68560 |
933 |
COP.DA-(D16Rat12-D16Rat90)/Mco |
plasma free fatty acids level |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood free fatty acid amount |
not specified |
105 days
| 8 |
|
0.13 |
mmol/l |
0.02 |
0.06 |
spectrophotometry |
0.0 |
0 |
|
|
68564 |
933 |
COP.DA-(D3Rat233-D3Mgh14)/Mco |
plasma free fatty acids level |
fasting (for 16 hours) |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood free fatty acid amount |
not specified |
105 days
| 20 |
|
0.22 |
mmol/l |
0.02 |
0.09 |
spectrophotometry |
0.0 |
0 |
|
|
68568 |
933 |
COP/OlaHsd |
plasma triglyceride level |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood triglyceride amount |
not specified |
105 days
| 14 |
|
0.58 |
mmol/l |
0.09 |
0.35 |
spectrophotometry |
0.0 |
0 |
|
|
68557 |
933 |
SS.MNS-(Mme-D2Rat131)/Ayd |
heart left ventricle deoxyribonucleic acid level to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
heart left ventricle DNA amount |
male |
98 days
| 5 |
|
3.7 |
ug/g |
0.3 |
0.67 |
spectrophotometry |
0.0 |
0 |
|
|
69038 |
1096 |
Hsd:WI |
liver malondialdehyde level to liver weight ratio |
acetaminophen (500 mg/kg) (for 1 days) then thymoquinone (15 mg/kg) (for 1 days) then fasting (for 16 hours) |
Aycan IO, et al., Int J Surg. 2014;12(3):213-8. doi: 10.1016/j.ijsu.2013.12.013. Epub 2014 Jan 2. |
liver malondialdehyde amount |
not specified |
0 days
| 10 |
|
0.45 |
nmol/g |
0.03 |
0.11 |
spectrophotometry |
0.0 |
0 |
|
|
85617 |
1618 |
F344/NHsd |
serum alanine aminotransferase activity level |
fasting (between 12 and 15 hours) then acetaminophen (1 g/kg) (for 1 days) |
McGill MR, et al., Toxicol Appl Pharmacol. 2012 Nov 1;264(3):387-94. doi: 10.1016/j.taap.2012.08.015. Epub 2012 Aug 23. |
blood alanine transaminase amount |
not specified |
56 days-84 days |
4 |
|
39.0 |
U/l |
4.0 |
8.0 |
spectrophotometry |
0.0 |
0 |
|
|
84755 |
1601 |
Y59/Zgd |
kidney malondialdehyde level |
vitamin A (80 mg/kg/d) (for 14 days) and alendronate (40 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
kidney malondialdehyde amount |
female |
105 days
| 5 |
|
10.5 |
nmol/mg |
0.73 |
1.63 |
spectrophotometry |
0.0 |
0 |
|
|
97491 |
1758 |
Y59/Zgd |
bone phosphorus content |
ethanol (0.5 %) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
bone mineral mass |
female |
105 days
| 10 |
mg/g bone tissue |
74.0 |
mg/g |
0.35 |
1.1 |
spectrophotometry |
0.0 |
0 |
660nm; Varian Cary 50 |
right |
97426 |
1758 |
Y59/Zgd |
bone phosphorus content |
vitamin A (80 mg/kg/d) (for 14 days) and naringenin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
bone mineral mass |
female |
105 days
| 10 |
mg/g bone tissue |
77.87 |
mg/g |
1.75 |
5.54 |
spectrophotometry |
0.0 |
0 |
660nm; Varian Cary 50 |
right |
97431 |
1758 |
Y59/Zgd |
liver malondialdehyde level |
vitamin A (80 mg/kg/d) (for 14 days) and chrysin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
liver malondialdehyde amount |
female |
105 days
| 5 |
|
8.04 |
nmol/mg |
0.72 |
1.6 |
spectrophotometry |
0.0 |
0 |
|
|
97483 |
1758 |
Y59/Zgd |
liver malondialdehyde level |
alendronate (40 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
liver malondialdehyde amount |
female |
105 days
| 5 |
|
6.6 |
nmol/mg |
0.56 |
1.26 |
spectrophotometry |
0.0 |
0 |
|
|
97485 |
1758 |
Y59/Zgd |
kidney malondialdehyde level |
ethanol (0.5 %) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
kidney malondialdehyde amount |
female |
105 days
| 5 |
|
9.7 |
nmol/mg |
0.93 |
2.08 |
spectrophotometry |
0.0 |
0 |
|
|
97489 |
1758 |
Y59/Zgd |
bone phosphorus content |
alendronate (40 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
bone mineral mass |
female |
105 days
| 10 |
mg/g bone tissue |
78.25 |
mg/g |
0.88 |
2.78 |
spectrophotometry |
0.0 |
0 |
660nm; Varian Cary 50 |
right |
97428 |
1758 |
SS.MNS-(D2Mit6-D2Rat166)/Ayd |
heart left ventricle deoxyribonucleic acid level to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
heart left ventricle DNA amount |
male |
98 days
| 4 |
|
5.0 |
ug/g |
0.5 |
1.0 |
spectrophotometry |
0.0 |
0 |
|
|
69036 |
1096 |
WKY.GHS-(D1Rat32-D1Mit32) |
urine calcium excretion rate |
controlled calcium content diet (1.2 %) (between 5 and 9 days) |
Hoopes RR Jr, et al., J Am Soc Nephrol. 2006 May;17(5):1292-304. Epub 2006 Apr 12. |
urine calcium amount |
female |
61 days
| 8 |
|
3.11 |
mg/d |
0.32 |
0.9 |
spectrophotometry |
0.0 |
0 |
|
|
67891 |
831 |
Hsd:SD |
serum alanine aminotransferase activity level |
fasting (between 12 and 15 hours) then vehicle control condition (for 1 days) |
McGill MR, et al., Toxicol Appl Pharmacol. 2012 Nov 1;264(3):387-94. doi: 10.1016/j.taap.2012.08.015. Epub 2012 Aug 23. |
blood alanine transaminase amount |
not specified |
56 days-84 days |
4 |
|
30.0 |
U/l |
1.0 |
2.0 |
spectrophotometry |
0.0 |
0 |
|
|
84757 |
1601 |
Y59/Zgd |
bone phosphorus content |
vitamin A (80 mg/kg/d) (for 14 days) and quercetin (100 mg/kg/d) (for 14 days) |
Orsolic N, et al., Eur J Nutr. 2014 Aug;53(5):1217-27. doi: 10.1007/s00394-013-0622-7. Epub 2013 Nov 23. |
bone mineral mass |
female |
105 days
| 10 |
mg/g bone tissue |
73.33 |
mg/g |
0.56 |
1.76 |
spectrophotometry |
0.0 |
0 |
660nm; Varian Cary 50 |
right |
97429 |
1758 |